Literature DB >> 24029221

Drop-out from addiction treatment: a systematic review of risk factors.

Hanne H Brorson1, Espen Ajo Arnevik, Kim Rand-Hendriksen, Fanny Duckert.   

Abstract

Completion of addiction treatment is one of the most consistent factors associated with a favorable treatment outcome. Unfortunately, it is more common for a patient to drop-out of addiction treatment than to complete the treatment. To prevent drop-out, risk factors must be identified. This box-score review focuses on studies investigating the risk factors associated with drop-out from addiction treatment published in peer-reviewed journals from 1992 to 2013. A total of 122 studies involving 199,331 participants met the inclusion criteria. Contrary to recommendations from previous reviews, 91% of the included studies focused primarily on enduring patient factors, mainly demographics. The most consistent risk factors across the different study designs, samples, and measurement methods were cognitive deficits, low treatment alliance, personality disorder, and younger age. With the exception of younger age, none of the demographic factors emerged as consistent risk factors. Further research on the relationship between simple demographic factors and drop-out risk is of limited value. However, little is known about the potential risk factors related to treatment programs and to the treatment processes. Based on the review, clinical recommendations include assessing cognitive functioning and personality disorders at baseline and continuous monitoring of treatment alliance.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Drop-out; Prediction; Review; Risk factor; Treatment

Mesh:

Year:  2013        PMID: 24029221     DOI: 10.1016/j.cpr.2013.07.007

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  118 in total

1.  Discharge against medical advice from hospitalizations for substance use disorders: The potential impact of the Affordable Care Act.

Authors:  He Zhu; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2019-02-16       Impact factor: 4.492

2.  Salience and default mode network dysregulation in chronic cocaine users predict treatment outcome.

Authors:  Xiujuan Geng; Yuzheng Hu; Hong Gu; Betty Jo Salmeron; Bryon Adinoff; Elliot A Stein; Yihong Yang
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

3.  Efficacy of Short-term Treatment of Internet and Computer Game Addiction: A Randomized Clinical Trial.

Authors:  Klaus Wölfling; Kai W Müller; Michael Dreier; Christian Ruckes; Oliver Deuster; Anil Batra; Karl Mann; Michael Musalek; Andreas Schuster; Tagrid Lemenager; Sara Hanke; Manfred E Beutel
Journal:  JAMA Psychiatry       Date:  2019-10-01       Impact factor: 21.596

4.  Moment-by-Moment in Women's Recovery: Randomized controlled trial protocol to test the efficacy of a mindfulness-based intervention on treatment retention and relapse prevention among women in residential treatment for substance use disorder.

Authors:  Hortensia Amaro; David S Black
Journal:  Contemp Clin Trials       Date:  2017-09-14       Impact factor: 2.226

5.  Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.

Authors:  Adam Viera; Daniel J Bromberg; Shannon Whittaker; Bryan M Refsland; Milena Stanojlović; Kate Nyhan; Frederick L Altice
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 6.222

6.  Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada.

Authors:  Andreas Pilarinos; Brittany Barker; Ekaterina Nosova; M-J Milloy; Kanna Hayashi; Evan Wood; Thomas Kerr; Kora DeBeck
Journal:  Addiction       Date:  2019-09-06       Impact factor: 6.526

7.  A Naturalistic Evaluation of a Group Intervention for Parents of Youth with Substance Use Disorders.

Authors:  Victoria Ameral; Amy Yule; James McKowen; Brandon G Bergman; Jessica Nargiso; John F Kelly
Journal:  Alcohol Treat Q       Date:  2019-07-01

8.  Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.

Authors:  Hillary Samples; Arthur Robin Williams; Mark Olfson; Stephen Crystal
Journal:  J Subst Abuse Treat       Date:  2018-09-07

Review 9.  Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders.

Authors:  Katie Witkiewitz; John W Finney; Alex H S Harris; Daniel R Kivlahan; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2015-08-11       Impact factor: 3.455

Review 10.  Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders.

Authors:  Katie Witkiewitz; John W Finney; Alex H S Harris; Daniel R Kivlahan; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2015-08-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.